A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from theMAINTAIN Nephritis Trial

Abstract

BackgroundAlthough an early decrease in proteinuria has been correlated with good long-term renal outcome in lupus nephritis (LN), studies aimed at defining a cut-off proteinuria value are missing, except a recent analysis performed on patients randomised in the Euro-Lupus Nephritis Trial, demonstrating that a target value of 0.8 g/day at month 12 optimised sensitivity and specificity for the prediction of good renal outcome. The objective of the current work is to validate this target in another LN study, namely the MAINTAIN Nephritis Trial (MNT).MethodsLong-term (at least 7 years) renal function data were available for 90 patients randomised in the MNT. Receiver operating characteristic curves were built to test the performance of proteinuria measured within the 1st year as short-term predictor of long-term renal outcome. We calculated the positive and negative predictive values (PPV, NPV).ResultsAfter 12 months of treatment, achievement of a proteinuria <0.7 g/day best predicted good renal outcome, with a sensitivity and a specificity of 71% and 75%, respectively. The PPV was high (94%) but the NPV low (29%). Addition of the requirement of urine red blood cells ≤5/hpf as response criteria at month 12 reduced sensitivity from 71% to 41%.ConclusionsIn this cohort of mainly Caucasian patients suffering from a first episode of LN in most cases, achievement of a proteinuria <0.7 g/day at month 12 best predicts good outcome at 7 years and inclusion of haematuria in the set of criteria at month 12 undermines the sensitivity of early proteinuria decrease for the prediction of good outcome. The robustness of these conclusions stems from the very similar results obtained in two distinct LN cohorts.Trial registration number:NCT00204022.

Time to recovery from Proteinuria and its related factors in patients with lupus nephritis

“…In this research most of LN patients were females (1,8,10) and male sex was a risk factor of the late proteinuria recovery (7). Grade IV had the highest frequency among patients in this study which is similar to other Iranian studied (9, 11).…”

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

“…This information could be useful when discussing prognosis with patients. Additionally, a proteinuria level of 0.7–0.8 gm/day after 12 months of treatment was recently identified as the best predictor of long‐term kidney survival compared to serum creatinine and urinary RBC status in a post hoc analysis of the Euro‐Lupus Nephritis Trial and MAINTAIN LN trials . These results were verified in an independent, ethnically diverse LN cohort .…”

Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis

“…The LUNAR trial's composite primary end point included the former criteria in addition to an inactive urinary sediment (fewer than five red blood cells per high-power field). For these analyses, urinary sediment was not included in the definition of complete response because of missing measurements and recent data demonstrating that sediment is not a useful predictor of long-term kidney outcomes (24,25). Inclusion of urinary sediment did not qualitatively affect the results presented here (see Supplemental Table 1).…”